Open for inclusion

Intra-hepatic chemotherapy with oxaliplatin every second week in combination with systemic capecitabine in patient with non-resectable liver metastases from breast cancer. A phase II trial in patients with limited extrahepatic disease

Cancer type: Breast cancer

Phase: II

Principal Investigator: Nielsen Dorthe

Country: DK

Keywords: Denmark, Herlev, Intra-hepatic chemotherapy, non-resectable liver metastases from breast cancer and limited extrahepatic disease

Status: Open for inclusion

Link to Clinicaltrials.gov: http://clinicaltrials.gov/ct2/show/NCT01387295?term=NCT01387295&rank=1